Livial Tablet contains Tibolone 2.5 mg, a synthetic steroid with estrogenic, progestogenic, and androgenic properties, primarily indicated for the treatment of menopausal symptoms and prevention of osteoporosis in postmenopausal women. Tibolone acts by mimicking the effects of natural hormones, thereby alleviating vasomotor symptoms such as hot flashes, night sweats, and mood disturbances associated with menopause. Additionally, it helps maintain bone density, reducing the risk of fractures in osteoporotic patients. Livial is typically prescribed for women who have undergone menopause or surgical removal of ovaries and require hormone replacement therapy (HRT). The tablet is administered orally, usually once daily, with or without food, as directed by a healthcare professional. Contraindications include known or suspected hormone-dependent malignancies, undiagnosed vaginal bleeding, active or past thromboembolic disorders, and liver impairment. Caution is advised in patients with cardiovascular disease risk factors. Common adverse effects may include vaginal bleeding, breast tenderness, abdominal pain, and headache. Regular monitoring and follow-up are essential to assess therapeutic efficacy and detect any potential side effects. Livial Tablet should be used under strict medical supervision to ensure safe and effective management of menopausal symptoms and osteoporosis prevention.